A Millimeter-scale Single Charged Particle Dosimeter for Cancer Radiotherapy

Kyoungtae Lee,Jessica Scholey,Eric B. Norman,Inder K. Daftari,Kavita K. Mishra,Bruce A. Faddegon,Michel M. Maharbiz,Mekhail Anwar

DOI: https://doi.org/10.48550/arXiv.2005.05071

2020-05-08

Abstract:This paper presents a millimeter-scale CMOS 64$\times$64 single charged particle radiation detector system for external beam cancer radiotherapy. A 1$\times$1 $\mu m^2$ diode measures energy deposition by a single charged particle in the depletion region, and the array design provides a large detection area of 512$\times$512 $\mu m^2$. Instead of sensing the voltage drop caused by radiation, the proposed system measures the pulse width, i.e., the time it takes for the voltage to return to its baseline. This obviates the need for using power-hungry and large analog-to-digital converters. A prototype ASIC is fabricated in TSMC 65 nm LP CMOS process and consumes the average static power of 0.535 mW under 1.2 V analog and digital power supply. The functionality of the whole system is successfully verified in a clinical 67.5 MeV proton beam setting. To our' knowledge, this is the first work to demonstrate single charged particle detection for implantable in-vivo dosimetry.

Instrumentation and Detectors

What problem does this paper attempt to address?

The problem that this paper attempts to solve is how to accurately measure the dose distribution of single charged particles in the body during cancer radiotherapy, especially when using proton beam therapy. Specifically, the paper proposes a millimeter - scale CMOS 64×64 single - charged - particle radiation detector system for external - beam cancer radiotherapy. The main objectives of this system are:

1. **Improve the accuracy of dose measurement**: Traditional dosimeters usually measure the average dose and ignore the different biological effects on tissues caused by single high - linear energy transfer (LET) particles compared with multiple low - LET particles. Due to this nonlinear relationship, single - particle detection is crucial for the next - generation in - vivo dosimeters and can analyze the real biological effects of radiation.

2. **Reduce range uncertainty**: In proton therapy, determining the exact position of the Bragg peak is a challenge because factors such as patient movement, changes in tissue atomic properties, and daily anatomical variations can all affect the stopping position of protons. The system proposed in the paper helps to more accurately locate the Bragg peak by real - time measurement of the energy deposition of single charged particles, thereby reducing range uncertainty.

3. **Achieve in - vivo implantation**: In order to achieve real - time in - vivo dose measurement, the system is designed to be millimeter - scale in size, can be implanted within a standard biopsy needle, and has very low power consumption, which is suitable for long - term biocompatible implantation (usually 1 - 8 weeks) and has an appropriate medical - grade package.

4. **Single - particle sensitivity**: The system can detect the energy deposition of single charged particles. This is achieved by measuring the time required for the voltage to return to the baseline (i.e., the pulse width), rather than the traditional method of measuring the voltage drop. This method avoids the need to use high - power - consumption and large - volume analog - digital converters.

In summary, this paper aims to develop a new type of single - charged - particle detector system to solve the problems of inaccurate dose measurement and range uncertainty in current cancer radiotherapy, thereby improving the safety and effectiveness of treatment.